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Nanoscale separation techniques, nanoscale packed capiIlary columns (75 pm id), and 
capillary zone electrophoresis (CZE), on-line with electrospray mass spectrometry (ESI/MS), 
were applied to the separation of a series of ten macrolide antibiotics. Both techniques use 
sub-microliter-per-minute flow rates through the analytical column and therefore require an 
electrospray probe that incorporates coaxial sheath flow. Positive ion electrospray mass 
spectra of these compounds yielded mainly protonated molecules. Fragmentation to yield 
structurally significant fragment ions was achieved by collision-induced dissociation (CID) 
at increased skimmer voltages. Separations were achieved using both techniques, with 
CZE/ESI/MS showing improved peak shapes and detection limits combined with faster 
analysis times. Nanoscale packed capillary columns provided better chromatographic reso- 
lution and was less susceptible to peak broadening caused by overloading of the analytes. 
(1 Am Sot Mass Spectrom 1992, 3, 563-574) 
M acrolides are a class of antibiotics produced by Streptomyces soil bacteria. Macrolides are widely used broad-spectrum antimicrobial 
agents, which are useful against gram-positive bacte- 
ria [l-4]. Erythromycin is perhaps the most com- 
monly prescribed macrolide in the United States, but 
other members of this class have been developed and 
are commonly used in other countries 15-91. 
Research in our Tokyo laboratory has involved the 
mechanisms of bacterial macrolide resistance. Our 
work, and that of other researchers, has indicated 
several mechanisms involving macrolide esterases and 
rRNA methylases 17, l&14] and 2’-phosphotransfer- 
ase [15-l&3]. 
The residual potency of the antibiotic in the reac- 
tion mixture with macrolide-inactivating enzyme has 
usually been determined by microbioassay. During 
the course of these studies, however, the need has 
become apparent for a physicochemical method capa- 
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ble of determining drug purity, degradation prod- 
ucts, and enzymatically induced structural changes 
in the macrolide. Because of the possibility of the for- 
mation of several products, a combination of a mass- 
spechometric technique with a separation technique 
would be desirable. These compounds cannot be ana- 
lyzed by direct electron or chemical ionization probe 
or by gas chromatography mass spectrometry 
(GC/MS). A liquid chromatography mass spectrome- 
try (LC/MS) approach, however, is a possibility. 
Historically, the difficulty in coupling conventional 
high performance liquid chromatography (HPLC) and 
mass spectrometry has been the basic incompatibility 
of the vacuum system with the large volume of mo- 
bile phase produced when operating at a flow rate of 
‘I ml/mm. Thii first led to the development of a 
variety of LC/MS interfaces designed either to re- 
move the solvent external to the ion source (moving 
belt) or to reduce the effective mobile-phase flow rate 
by means of a postcolumn splitter (direct liquid intro- 
duction, DLI). A step toward improving the perform- 
ance of both of these interfaces was the reduction of 
column effluent volume through the use of microbore 
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or minibore HPLC columns, with flow rates of XI-200 
pL/min. Neither interface was ideal, however, be- 
cause thermal degradation and memory effects could 
be encountered with the moving-belt interface, and 
plugging of the pinhole often occurred with the DLI 
interface. The thermospray interface, with its ease of 
operation and its ability to handle l-mL/min flow 
rates, overshadowed the other LC/MS techniques 
soon after its introduction. We have been involved in 
a research program aimed at the development of 
nanoscale separation techniques-nanoscale packed 
capillary liquid chromatography (nCLC) [19-221 
and capillary zone electrophoresis (CZE) [23-27]- 
characterized by sub-microliter-per-minute flow rates, 
in conjunction with mass spectrometry. We have in- 
terfaced these techniques to both continuous flow fast 
atom bombardment (CF-FAB) and electrospray mass 
spectrometry, both of which can efficiently handle 
these mobile-phase flow rates. 
Capillary zone electrophoresis, developed by 
Jorgenson and Lukacs [28], employs capillary tubes, 
usually made of fused silica, with inner diameters of 
10-100 pm. The column is filled with a buffer solu- 
tion, a voltage potential is applied across the capillary 
tube, and separation of analytes with different partial 
charges occurs as a result of their differential migra- 
tion in the electric field. The separation is primarily a 
function of charge with secondary contributions from 
molecular size and shape [29]. The voltage drop across 
the column is typically 30 kV (300 V/cm). CZE has a 
pistonlike flow profile rather than a parabolic flow 
profile; hence separation efficiencies are extremely 
high [29]. Relative electrophoretic migration times (the 
operational equivalent of HPLC retention times) are a 
function of both electromigration of the analyte in the 
electric held, and the electroosmotic flow (i.e., the 
liquid flow resulting from the movement of highly 
solvated ions). This liquid flow is usually 50-350 
nL/min. Electrophoretic migration times can be al- 
tered by adjusting the pH, by changing the buffer 
composition (restricted to volatile buffers when cou- 
pled to mass spectrometry), or by adding an organic 
modifier to the buffer to reduce the electroosmotic 
flow. In addition, chemical modification of the capil- 
lary walls has allowed improved separations of posi- 
tively charged analytes, particularly basic compounds, 
by preventing adsorption [30]. 
and neutral species to “ground” regardless of the 
sign of the charge. A review of CZE/MS, including a 
more detailed description of CZE, has recently been 
published [27]. 
The second sub-microliter-per-minute technique is 
nCLC. Standard HPLC column packings are used, 
either reversed-phase or normal-phase, and standard 
HPLC techniques such as gradient operation are avail- 
able. Instead of a 4.6-mm id column, 75-pm id fused 
silica capillary columns with mobile-phase flow rates 
of 50-800 nL/min have been used. This LC column id 
eliminates many of the problems associated with the 
smaller open-tubular LC columns, which had very 
low loading capacities [31], and with microbore 
columns, which suffered from band broadening due 
to differences between the column packing bed in the 
interior of the column and that near the wall [32]. For 
column id-to-particle diameter ratios of less than 10, 
the entire packing bed will be uniform, resulting in 
increased separation efficiencies [32, 331. 
Treatment of the fused silica column with 3- 
aminopropyltrimethoxysilane (AI’S) changes the 
charge- on- the column wall from the negative charge 
found in bare fused silica to a positive charge, due to 
the presence of the amino propyl groups. This change 
in the charge on the walls leads to a change in the 
direction of electroosmotic flow because, under these 
conditions, the electroosmotic flow is driven by an 
excess of negative ions in solution. Thus the direction 
of the electroosmotic flow is from high negative po- 
tential to ground. The electroosmotic flow in CZE is 
typically strong enough to sweep charged analytes 
In electrospray ionization (ESI), a recently ex- 
ploited mass-spectrometric technique, small, highly 
charged droplets are generated from a solution by 
passing the solvent stream through a needle at high 
voltage [34, 351. No pinhole is used to generate the 
spray; instead, a plume is formed by the charge repul- 
sion of the droplets. Sample ions are formed from the 
droplets, possibly by an ion evaporation mechanism 
[36]. Flow rates for the generation of the spray are 
- 5-10 pL/min. Unlike conventional HPLC, the flow 
rates generated by both CZE and nCLC are actually 
lower than ideal for this interface but can easily be 
augmented by the addition of a makeup solution. 
CZE/ESI/MS, with the makeup flow introduced 
either coaxially 126, 37, 381 or via a liquid junction 
[39], has been reported. 
Electrospray (ion spray or nebulization-assisted 
electrospray [40]) is a very gentle ionization tech- 
nique; resulting spectra contain mainly molecuIar ions 
with limited fragmentation. Electrospray has been 
successfully used for the analysis of a wide variety of 
compounds, including proteins and peptides [21, 26, 
39, 41-451, azo dyes 140, 461, and marine neurotoxins 
[47, 481. Electrospray mass spectra of drugs represent- 
ing diverse classes have been reported, including 
gramicidin S [35]; morphine, codeine, and cocaine 
[49]; insulin [SO]; and quaternary ammonium drugs 
[511. 
We now report the results of our study of the 
application of CZE and nCLC in conjunction with ES1 
for the analysis of macrolide antibiotics. 
Experimental 
Instrumentation 
The mass spectrometer data system used was a VG 
12-250 quadrupole mass spectrometer and data sys- 
tern (VG/Fisons, Altrincham, UK). Reference spectra 
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of the standards were acquired over the mass range 
100-1200 u at a scan rate of 10 s/scan. The mass range 
employed was 400-1200 u at 5 s/scan for the 
nCLC/ESI/MS, acquired in the peak centroid mode. 
Selected ion monitoring (SIM) on the eight masses 
of the protonated molecules was used for the 
CZE/ESI/MS. 
A Vestec electrospray source, model 611B (Vestec 
Corp., Houston, TX), was used throughout the exper- 
iments. This source differs from other electrospray 
source designs [35] in that it does not rely on the use 
of a nitrogen curtain gas but instead uses a heated 
block for desolvation [52]. The block was held at 266 
“C, and the chamber temperature was kept at 55 “C. 
The needle voltage was held at - 3 kV, giving a 
spray current of approximately 0.2-0.25 PA, and the 
skimmer voltage was varied between 4 and 55 V. 
Valco tee. The original metal sleeve around the probe 
handle has been replaced with plexiglass to prevent 
electrical discharge, and both metal endplates of the 
probe handle must be grounded. This electrospray 
probe design allows separations to be performed at 
the sub-microliter flow rates while total flow at the 
needle tip can be kept at the - 5-10 pL/min required 
for stable electrospray operation. In addition, this 
design permits independent optimization of the sepa- 
ration column conditions and of the sheath flow 
conditions. 
The probe used was of a coaxial flow design. The 
concept of coaxial flow for use with capillary columns 
was originally developed for the postcolumn derivati- 
zation of analytes following capillary column chro- 
matography where the introduction of additional 
solution could be delivered to the capillary tip with- 
out loss of chromatographic resolution [53]. The prin- 
ciple of coaxial flow has been used by Smith and co- 
workers for electrospray [37, 381 and has previously 
been used in our laboratory for the combination of 
nanoscale separations with continuous-flow fast atom 
bombardment (FAB) [19-27, 541. In our CZE/nCLC 
probe, which was modified from the standard Vestec 
ES1 probe, the analytical capillary passes through a 
Valco “tee” union, through a l/%-in. stainless steel 
tube, and through the union holding the electrospray 
needle (Figure 1). The analytical capillary protrudes 
slightly from the end of the needle but is still within 
the Taylor cone [55]. Sheath flow is introduced 
through one side of the tee and flows through the 
interstitial space between the analytical capillary and 
the stainless steel tubing and electrospray needle, The 
electrical connection to the needle is made at the 
The electrospray needle should be as small as pos- 
sible, with an inner diameter just large enough for the 
column to pass through. For nCLC work, where 75-pm 
id x 150-pm od fused-silica capillary tubing is used, 
the needle is made from 0.007-in. id x 0.013-in. od 
tubing. For CZE work, it was found that thicker-walled 
tubing led to more reliable operation (fewer problems 
of electrodrilling holes through the capillary wall), so 
75-pm id x 360-pm od capillary is used. The needle 
size used for CZE operation is cut from 0.017-in. 
id x 0.028-in. od stainless steel tubing. 
CZE System 
The CZE apparatus was constructed in house and 
has been described elsewhere [23-25, 271. It uses a 
Glassman HV power supply (Glassman High Voltage, 
Whitehouse Station, NJ), which was operated at +30 
kV or - 30 kV in these experiments. The high voltage 
end of the CZE capillary is located in a plexiglass box, 
and the CZE “ground” is the electrospray needle 
itself (at - +3 kV) so that the effective voltage drop 
was 27 or 33 kV. 
Injections were made by raising the end of the 
electrophoresis capillary above the level of the electro- 
spray needle, placing the end of the electrophoresis 
capillary in the sample solution, and allowing siphon- 
ing of the sample into the capillary tube for a timed 
interval. The end of the capillary is then placed in the 
Stainless Steel 
Needle Stainless Steel 
.013” o.d. Stainless Sleel Tubing 
Analytical 
Capillary 
Sheath Flow 
Capillary 
325 p i.d. 
425 p o.d. 
Figure 1. Schematic of CZE and nCLC/ESI/MS probe. The probe is shown with the needle used 
for nCLC work. For CZE analyses, where a larger od fused silica capillary is used, the needle size 
was 0.017 in. id and 0.028 in. od. 
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CZE buffer, and the voltage is applied to initiate the 
electrophoretic separation. Electroosmotic flow rates 
through the 75-pm id capillary are 300-400 nL/min. 
Because ES1 requires 5-10 pL/min total flow to gener- 
ate a stable spray, makeup sheath flow is required 
and was generated in these experiments by a Harvard 
Apparatus model 909 syringe pump (Harvard Appa- 
ratus, South Natick, MA). For separations of the 
macrolides with neutral or basic mobile phases (pH 7, 
8.5, and 9), untreated silica capillary was used. For 
the separations of the macrolide antibiotics with acidic 
mobile phases (pH 2.35, 2.6, 3.4, 5, and 7), the CZE 
capillary was treated with AI’S [25]. The buffers em- 
ployed for the separations were 0.01-M acetic acid or 
ammonium acetate; pH adjustments were made with 
ammonium hydroxide or acetic acid down to pH 3.4. 
For pH below 3.4, formic acid and trifluoroacetic acid 
were used to achieve the desired pH values. 
nCLC System 
The nCLC column used was a 2-m x 75-Frn id, 150-pm 
od fused-silica capillary packed to a depth of 25 cm 
with lo-pm AQ-Cl8 (YMC Inc., Morris Plains, NJ). 
The column preparation procedure has been de- 
scribed in detail elsewhere [22]. Mobile-phase flow 
through the analytical column was generated using a 
Gilson Gradient HPLC system and controller, oper- 
ated at 0.8 mL/min. Flow through the capillary col- 
umn was reduced by a factor of 1000 with a splitting 
tee. A 34-cm length of 75.pm id capillary was used to 
provide the back-pressure required to force approxi- 
mately 800 nL/min of mobile phase through the capil- 
lary column. 
A water-acetonitrile gradient (25% to 100% over 30 
min, with both mobile-phase solvents containing 0.1% 
TFA) was employed for the separation. As with the 
CZE/ESl/MS, a sheath flow consisting of 50-50 
methanol-3% aqueous acetic acid was used. The 
sheath flow was delivered using a Harvard syringe 
pump, model 909 (Harvard Apparatus, South Natick, 
MA). 
Injections onto the analytical column were per- 
formed by placing the end of the column into the 
sample vial in a stainless steel pressure vessel [54, 561. 
Samples were forced onto the column by pressurizing 
with helium for a timed interval. 
Chemicals 
Structures and names of the macrolide antibiotics 
studied are shown in Figure 2. Standard samples of 
erythromycin A (EMA), oleandomycin (OL), spi- 
ramycin (SPM), and tylosin (TYL) were purchased 
from Sigma Chemical Co. (St. Louis, MO). Trolean- 
domycin (TAO), formerly known as triacetylolean- 
domycin, was a gift from Sankyo Co., Ltd. (Tokyo), 
and josamycin (JM) was a gift from Yamanouchi Phar- 
maceutical Co., Ltd. (Tokyo). Midecamycin (MDM) 
and miokamycin (MOM) were a gift from Meiji Seika 
Kaisya, Ltd. (Tokyo). Leucomycin-A5 (LM-A5) was 
purchased from Wako Pure Chemical Industries 
(Osaka, Japan). Rokitamycin (RKM) was purchased 
from Toyo Jozo (Tokyo). Compounds were used with- 
out further purification. 
Mobile phases consisted of HPLC-grade acetoni- 
trile and methanol (Fisher Scientific, Fairlawn, NJ). 
Water was obtained from a Milli-Rho/Mill&Q system 
(Millipore Corp., Bedford, MA). Trifluoroacetic acid 
was from Fairfield Chemical Co., Blythewood, SC. 
Bacterial Digests 
For study of the OL inactivation products, 0.5 mg OL 
was combined with 800 mL bacterial extract (contain- 
ing the inactivating enzyme) and 200 mL 80-mM ATP 
in pH 7.8 TMK buffer (0.06-M KCl, 0.01-M magne- 
sium acetate, and 0.006-M 2-mercaptoethanol in 0.1-M 
Tris-HCI). An aliquot was taken at the beginning of 
the reaction and was designated as OL-Oh. A second 
aliquot was obtained after reaction at 37 “C for 24 h 
and was designated as OL-24h. Both aliquots were 
heated at 100 “C for 3 min to stop the enzymatic 
reaction. The solutions were centrifuged at 5000 g 
for 15 min, and the supernatant was taken and 
lyophilized. A 2-mg portion of each sample was re- 
constituted in 200 pL water and analyzed by nCLC. 
The gradient used for these samples was the same as 
that employed for the standards, except for the incor- 
poration of a 15-min wash at 100% H,O (0.1% TFA) at 
the start of the analysis to assist in the removal of 
salts. 
Results and Discussion 
Fragmentation Patterns and Skimmer 
Voltage Effects 
Macrolides are comprised of an amino sugar (B), a 
nitrogen-free sugar (S), and a 14- or 15-membered 
ring aglycone portion (A) (see Schemes 1 and 11). The 
nitrogen-free sugar (5) and the amino sugar (B) can 
either be both attached directly to the aglycone (A) to 
give a structure with the shorthand notation SOAOB, 
or the sugar (S) can be bound to the amino sugar (B), 
which is then bound to the aglycone (A) to give a 
structure with the shorthand notation AOBOS. 
Electrospray spectra of the individual macrolide 
antibiotics were obtained by continuous infusion of 
solutions (1 mg/mL in 50-50 water-methanol) through 
a 75-pm id fused-silica capillary. Tabulated spectra for 
the macrolides studied are given in Table 1, and ES1 
mass spectra for JM, at skimmer potentials of 11, 25, 
and 40 V, are shown in Figure 3. At low skimmer 
voltages, most of the macrolide antibiotics yielded 
abundant protonated molecules. At higher skimmer 
voltages, fragment ion relative abundances increased, 
with a concomitant loss of protonated molecule 
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STRUCTURES OF COMPOUNDS STUDIED 
16-membered rlna macrolldes 
~omoound !a 
Midecamycin (MDM) DCDCH,CH, 
Miokamycin (MOM) OCOCH,CH, 
Leucomycln-A6 (LM) OH 
Rokitamycln (AKM) OH 
Josamycin (JM) OCOCH, 
Spiramycin (SPM) OH 
Tylosin (WL) OH 
14-membered rina macrolides 
Cgmoound 
Erythromycin A (EMA) 
Oleandomyeln (OL) 
Troleandomycin (TAO) 
G.6 
CH,, OH 
CH, H 
CH,, H 
CH, 0 
Mldecamycin (MDM) 
!a 
OCH, 
OCH, 
OCH, 
OCH, 
OCH, 
OCH, 
‘X 
&2! cl4cai 
OH H CH, 
OCOCH, H CH, 
OH H CH, 
OH H CH, 
OH H CH, 
$-& H CH, 
a 
=o n CH$H, 
H,C, .CH3 N 
Erythromycln A (EMA) 
!-$J w 
CH,, OH OCOCH$H, 
CH,, CCOCH, 0COCH2CH, 
CH,, OH 0COCHzCH2CH, 
CH,, OCOCH,CH, OCOCH$H,CH, 
CH, OH OCOCH&W(CH,), 
CH, OH OH 
CH,, Ott OH 
!a c_ll 4x2 !x3 !a! E?t citr 
CH, OH CH,, OH CHrCH, OH OCH,, CH, OH 
CH,O OH CH,, H CH, OH OCH,, H OH 
CH,O OCOCH, CH, H CH, OCOCH, OCH,, H OCOCH, 
Figure 2. Structures of compounds studied (Lh4 = Lh4 ~ A5). 
abundance. Skimmer voltage-induced CID effects in Vestec source [52]. The changes in ion abundance are 
atmospheric pressurized ionization (API) sources have 
been reported by several research groups [57-591 and 
shown in Figure 4 for MDM, a 16-membered ring 
have been described for the Fenn-Whitehouse API- 
macrolide, and TAO, a 1Cmembered ring macrolide. 
electrospray source [35] by Loo et al. [60] and as 
For these compounds, a skimmer setting of 11 V gave 
the most abundant protonated molecule signal, and a 
occurring in the skimmer-collimator region in the skimmer voltage setting of 25 V was the best choice if 
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structural information, as well as molecular weight 
information, was desired. The ion abundance of the 
(M + Na)+ showed less of a decrease with increasing 
skimmer voltage than the (M + H)+ ion. This phe- 
nomenon has also been observed for sulfonamides 
[61] and may prove useful in distinguishing between 
protonated and sodiated species. 
Fragmentations of these protonated molecules are 
quite predictable (Schemes I and II) and typically 
OLEANDOMYCIN 
m.r. 687 
[SOAOBI 
[M+K(SH)]’ S’ 6’ 
mlz5-44 rmZl45 m/z158 
Scheme II 
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produce an ion from the sugar ring (S+), an ion from 
the B ring plus oxygen (BOH)*, and an ion arising 
from loss of the sugar from the protonated molecule 
[M + H - (S - H)]+. In macrolides where the S ring 
is attached directly to the macrolide ring (A), the ion 
B+ is observed in lieu of the (BOH)+ ion. For LM-A5, 
which has an esterifred hydroxyl group (O&R) on the 
sugar, the OCR portion of the ester is lost as a 
substituted ketene from the protonated molecule to 
give [M + H - (OCR - H)]+. An ion formed by loss 
of carboxylic acid from the tertiary carbon, (S - 
HO&R) +, is observed for MDM and RKM. Similar 
fragmentations have been observed in the FAB mass 
spectrum of OL [15], and similar reaction pathways 
have been described for the FAB mass spectra of 
steroid and flavonoid glycosides [62]. 
In general, more abundant fragment ions are ob- 
served for the 16-membered macrolides than for the 
1Cmembered ring macrolides. These same macrolides 
also have both the sugar rings (S) and the aminosugar 
rings (B) attached directly to the macrolide ring rather 
than in series, and we are therefore unable to distin- 
guish which structural feature may account for this 
difference. 
One macrolide, RKM, has two B rings. Under elec- 
trospray ionization, this compound shows a doubly 
protonated molecule, resulting from protonation of 
both N(CH,), groups, as well as a singly protonated 
molecule. The abundance of the doubly charged ions 
decreases with increasing skimmer voltage. 
CZE Separations 
Our first approach to combining a separation step 
with ES1 for the analysis of mixtures of macrolides 
was to try CZE/ESI/MS. CZE separations were done 
at various pH levels ranging from pH 2.35 to pH 9. 
When basic mobile phases were used, the separations 
were carried out in an untreated silica capillary at 30 
kV CZE voltage. At acidic pH levels, separations were 
done in an APS-treated silica capillary at - 30 kV CZE 
voltage. An initial problem encountered was column 
overloading. High sample loadings in CZE (ng levels) 
resulted in broad unresolved peaks. This is one of the 
limitations of the CZE approach-overloading of the 
capillary can readily occur. Using our present 
CZE/ESI/MS system, the upper limit of loading onto 
the column is often very close to the lower limit of 
detection of our quadrupole mass spectrometer under 
full scan conditions, leading to a very narrow dy- 
namic range. For this reason, data were acquired in 
the selected ion monitoring (SIM) mode for the CZE 
analyses. 
To avoid overloading and to be able to distinguish 
between components of the same molecular weight, 
two separate mixtures of the macrolide antibiotics 
were used in the CZE/MS experiments-one mixture 
of six macrolides (TYL, RKM, MOM, MDM, EMA, 
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Figure 3. ES1 mass spectra of JM at skimmer voltages 11, 25, 
and 40 V. 
and SPM) and a second mixture of four antibiotics 
(JM, LM-AS, OL, and TAO). Separations were inves- 
tigated at a series of pH levels: pH 7, 8.5, and 9 using 
a plain fused-silica capillary and pH 2.35, 2.6, 3.4, 5, 
and 7 using an APS-treated capillary. During the 
study at acidic pH levels, it was noted that the addi- 
tion of TFA, needed to reach the lowest pH value, led 
to a reduction in sensitivity. Addition of an organic 
modifier, 2-propanol, was investigated at pH 3.4 and 
pH 8.5 in an attempt to improve the separation [63]. 
As expected, changing the CZE buffer to one contain- 
ing 10% 2-propanol decreased the electroosmotic flow 
SKIMYER.lNDUCED CID 
0 10 &nnl.:“Y,l,a~~ 50 60 
Figure 4. Relative ion abundances as  function of skimmer 
voltage for midecamycin (MDM) and troleandomycin (TAO). 
rates, leading to longer analysis times. Unfortunately, 
separations were not improved. 
Optimal separations by CZE were obtained at ei- 
ther pH 8.5 on untreated silica or pH 3.4 on an 
APS-treated column. The pH 3.4 separations (Figure 
5a and b) were the best obtained overall because peak 
widths were narrower than at pH 8.5 (approximately 
190,000 theoretical plates for OL in Figure 5a). Analy- 
sis time was rapid, with all of the components eluting 
within 7 min at pH 3.4 and 10 min at pH 8.5. 
Approximately 44 fmol of each component was 
injected on-column in Figure 5a, whereas 300 fmol of 
each macrolide was used to produce the electrophero- 
grams in Figure 5b. Figure 5b illustrates the variation 
in sensitivity among the macrolides, EMA being the 
most sensitive and MOM being the least sensitive 
(and the least stable) of these compounds; it also 
demonstrates the effect of column overloading. To 
detect the MOM peak, approximately seven times as 
much material was injected as in Figure 5a. As can be 
0 ___ ^.- 
b “s;, 
- ,: ,.,,, 
545 6.00 615 630 s:45 7 w 7 15 7:30 TIME 
Figure 5. (a) Selected ion electmpherogmms for the proto- 
nated molecules from a mixture of four macmlide antibiotics 
separated by CZE/ESf /MS. Buffer: 0.01-M acetic acid, pH 3.4. 
Column: 1.1 m x 75 pm id AI’S, Amount injected: - 44 fmol. 
(b) Selected ion electropherogmms for the pmtonated molecules 
from a mixture of six macrolide antibiotics separated by 
CZE/ESI/MS. Buffer: 0.1-M acetic acid, pH 3.4. Column: 1.1 
m x 75.pm id AI’S Amount injected: - 300 fmol. 
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seen by comparing the peak widths in Figure 5a and 
b, the effect of overloading the CZE column led to 
peak broadening and a reduction in fhe number of 
theoretical plates-EMA shows only 30,000 theoretical 
plates in this analysis. 
Unfortunately, we were unable to obtain baseline 
separations of the macrolides by CZE. Because WE 
separations are based primarily on the partial charge 
on the molecule with secondary contributions from 
molecular shape and weight, it is not surprising that 
these structurally similar compounds do not readily 
separate in WE. The separations obtained at these 
two pH levels were, in effect, “opposites” of each 
other, with the later-eluting peaks on silica being the 
earlier-eluting peaks on APS, and vice versa. In both 
AI’S and silica separations, differences in elec- 
trophoretic migration times among the other 
maaolides are small but reproducible. 
As expected for a group of compounds with the 
same functional groups, CZE separations are based 
only on the molecular weights of the compounds. 
CZE can separate OL (mol wt 687) and EMA (mol wt 
733) from TYL (moI wt 915) but cannot resolve the 
compounds that differ by only 14 u in molecular 
weight, such as MDM (mol wt 813), RKM (mol wt 
827), and JM (mol wt 827). Identihcation of these 
compounds based solely on their electrophoretic mi- 
gration times by CZE/lJV, for example, would be 
impossible. The advantage of doing the analysis by 
CZE/ESI/MS is that the compounds, even if overlap- 
ping, can be distinguished on the basis of their molec- 
ular weights and fragment ions. 
SPM showed two peaks at pH 8.5 and at pH 3.4 
when run in the mixture and separately. The peak 
migrating differently from the other macrolides may 
be due to the formation of a doubly charged analyte, 
as SPM is the only one of these macrolides with two 
amine groups. The other peak that appears in the 
same m/z 843 window may be due to a different 
isomer or an impurity, whose identity could not be 
determined from these SIM/MS experiments. 
nCLC Sepurutiuns 
used for the nCLC separation as were used for the 
CZE separations. A mixture of 15 pmol of each of the 
four antibiotics shown in the CZE experiments (Figure 
5a) was chromatographed using a simple linear gradi- 
ent, and all four components were readily separated 
(Figure 6a). The peak occurring at scan 307 in the 
reconstructed ion chromatogram for LM-A5 was due 
to a degradation product of the TAO sample solution, 
which will be discussed later. 
An nCLC separation on the same mixture of six 
macrolide antibiotics used in the CZE separations 
shown in Figure 5b was performed with 30 pmol of 
each antibiotic injected onto the column. All six com- 
ponents were readily resolved through application of 
the same linear gradient (Figure 6b), with SPM being 
very close to its detection limit. (SPM was below the 
detection limit by CZE when data were acquired in 
LM-AS 
TYL 
Because the separations achieved by CZE were lirn- 
ited (although sufficient for some applications when 
combined with mass-spectral differentiation), we ex- 
plored combined nCLC/ESI/MS for these corn- 
pounds. One of the main advantages of the nCLC 
approach, when used in conjunction with the 
quadrupole mass spectrometer, is its increased sam- b 5% 120 
ple loading capacity. CZE column overloading oc- 
ii% 
240 300 360 420 
10:19 20:39 25 40 30% 359 TIME 
curred when higher levels of analyte (necessary for 
Figure 6. (a) Reconstructed on chromatograms from a mixture 
the acquisition of full scan data) were injected. Fur- 
of four antibiotics separated by nCLC/ESI/MS. Packed capillary 
LC column: 2 m x 75-pm id, 25 cm packed with E-pm AQ 
thermore, the ability to perform gradient analyses C-18. Gradient 25-100% (30 min) CI-@J:H,O (both 0.1% TFA). 
with nCLC ereatlv aids method develoDment. and it Amount injected: - 15 pmol. (b) Reconstructed ion chro- 
also allows &-column sample precon&ntratidn from matograms from a mixture of six antibiotics separated by 
dilute solutions. 
nCLC/ESI/MS. Packed capillary LC column: 2 m x 75 pm id, 
25 cm packed with 10.hrn AQ C-18. Gradient 25-100% (30 min) 
For ease of comparison, the same mixtures were CH,&: H,O (both ll:l% TFA). Amount injected: - 3d pmol.’ 
572 PARKER ET AL. J Am SIX Mass Spectrum 1992,3, 563-574 
the full scan mode.) The multiple peaks in the mass 
window corresponding to TYL may result from iso- 
mers of the drug. 
Spectra obtained for JM and MOM during the 
analyses illustrated in Figure 6a and b are shown in 
Figure 7. These demonstrate the simplicity of the 
spectra obtained using the electrospray interface at 
low skimmer voltage. 
nCLC/ ESI Applications 
Two applications of the nCLC/ESI technique to the 
analysis of macrolides antibiotics are reported here. 
The first involves the structural determination of a 
degradation product from TAO, and the second in- 
volves the analysis of inactivated OL from a bacterial 
digest. 
TAO degradation product. The reconstructed ion chro- 
matogram for m/z 772, the mass of the protonated 
LM-A5 molecule, showed two peaks. The chromato- 
graphic peak occurring at scan 307 in the recon- 
structed ion chromatogram in the nCLC separation 
shown in Figure 6b was traced to a degradation prod- 
uct of the TAO sample solution. 
This TAO degradation product, which has the same 
molecular weight as LM-A5, could be differentiated 
from LM-A5 by its retention time and by the presence 
of a fragment ion at m/z 586. Based on its molecular 
weight and its presence in TAO, this degradation 
product is probably a diacetyloleandomycin resulting 
from hydrolysis of one acetate ester. On the basis of 
its ES1 mass spectrum, it is possible to deduce which 
acetyl group is “missing”. The ion of m/z 586, noted 
in its spectrum, arises via loss of a monoacetylated S 
ring, [M + H - (S - H)]+. Thus the S ring still re- 
tains an acetyl group. Another fragment ion can be 
observed (at 25 V skimmer voltage) at m/z 158, which 
can be assigned as a B+ fragment. This ion is 42 u 
lower in mass than the B+ ion from TAO, indicating 
JM 
Figure 7. On-line ES1 mass spectra obtained for JM and MOM 
kom the nCLC analyses shown in Figure 6. 
that the acetyl group has been lost from the B ring. 
Hence, based on its ES1 mass spectrum, the degrada- 
tion product in the sample solution is a diacetylolean- 
domycin with acetyl groups on the A and S rings. 
Bacterial digest. To determine if the nCLC method 
could be applied to the analysis of products resulting 
from bacterial inactivation of macrolide antibiotics, a 
digest of OL and bacterial extract was prepared. A 
sample containing all of the reagents but in which the 
inactivation reaction was stopped immediately was 
designated “OL-Oh”; the sample in which the enzy- 
matic reaction was allowed to proceed for 24 hours 
was designated “OL-24h”. Earlier experiments in- 
volving bioassays had indicated the formation of an 
inactivated OL in the reaction mixture, designated 
“IOL”. Off-line FAB/MS experiments on purified IOL 
had indicated the presence of phosphorylated OL as 
the enzymatic reaction product, with protonated 
molecular weight of 768 u [25]. 
nCLC/ESI analysis of the OL-Oh sample showed 
only unreacted OL, whereas the OL-24h sample 
showed almost no OL but instead an earlier-eluting 
product of m/z 889. A mixture of these two samples 
was used to produce the chromatograms in Figure 8a 
and b, showing the separation. The on-line mass 
spectrum of the m/z 889 product (Figure 8c) also 
showed an ion corresponding to the loss of 144 u, 
which was attributed to an [M + Na - (S - H)]+ ion. 
This indicates that the sugar ring is unchanged from 
that of OL. In addition to this product, a trace of the 
a 
Figure 13. Reconstructed ion chromatograms of the OL reaction 
product (a) and unreacted OL from an nCLC/ESI analysis of the 
mixture (b), and ES1 mass spechum of the reaction product (c). 
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expected phosphorylated OL (IOL) was also observed 
at m/z 790 (corresponding to [M + Na]+). The dif- 
ference in mass between IOL and the new product is 
121 u, so the new product appears to be a condensa- 
tion product, complex, or adduct of IOL with a Tris 
molecule (IOL + Tris + H)+. This m/z 889 com- 
pound is not likely to be a physiological product of OL 
but is most likely an artifact resulting from ly- 
pophilization of the 1OL in the Tris solution, which 
led to a highly concentrated solution before evapora- 
tion. Some (OL + Tris + H)+ and (OL + Tris + Na)+ 
adduct was detected by nCLC/ESl as well. The ex- 
traction procedure previously used for generation of 
IOL involved extraction into BuOH prior to lyphiliza- 
tion, and thus the IOL was not exposed to highly 
concentrated Tris buffer. Further studies involving 
FAB MS/MS analysis of the adduct are in progress, 
but nCLC has been shown to be valuable in the 
identification of macrolide inactivation products as 
well as for extraction procedure evaluation. 
packed nCLC column is easy and rapid, taking only 
about 10 min. 
Conclusion 
Positive-ion electrospray ionization of macrolide an- 
tibiotics yields spectra with abundant protonated 
molecular ions. Fragmentations useful for structure 
determination can be enhanced by increasing the 
skimmer voltage. 
Comparisons of CZE / ESl/ MS and 
nCLC/ ESlmS 
From a practical point of view, nCLC is advantageous 
in terms of ease of operation for those versed in the 
use of larger id columns. Use of these small packed 
capillary columns is as easy as conventional HPLC, 
and column preparation is not difficult or time- 
consuming. A further advantage is the ability to trans- 
fer previously developed conventional I-II’LC method- 
ologies directly to the nCLC columns. Of the two 
techniques, analysis using CZE/ESI/MS is sign& 
cantly more rapid while providing increased separa- 
tion efficiency (i.e., narrower peaks) and thus en- 
hanced detection limits (by approximately an order of 
magnitude for full scan data). Chromatographic reso- 
lution by CZE, however, was much poorer than by 
nCLC, due to similarities between the molecules in 
size, shape, and charge. A major disadvantage of 
CZE/ESI/MS using this system was the ready occur- 
rence of column overloading. 
Separation of synthetic mixtures of macrolide 
antibiotics can be achieved using either CZE or 
nCLC, but the higher loading capacity of the nCLC 
column proves distinctly advantageous where mass- 
spectrometric sensitivities are limiting. However, UE 
peak widths are narrower, detection limits are lower, 
and the analysis times are shorter, but for this group 
of closely related compounds, chromatographic sepa- 
rations were better by nCLC. Both techniques are 
readily interfaced with the mass spectrometer using 
the electrospray probe where the sub-microliter-per- 
minute flow rate of the analytical techniques is sup- 
plemented by coaxial delivery of additional solution 
required for stable electrospray operation. 
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